David Altarac
Dr. David Altarac serves as the chief medical officer at Innoviva Specialty Therapeutics, where he contributed to the development of zoliflodacin, a new antibiotic approved for treating gonorrhea, helping to address the growing issue of antibiotic resistance.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. David Altarac, chief medical officer at Innoviva Specialty Therapeutics, discussed the potential of zoliflodacin to strengthen treatment options against gonorrhea.
9